LJPC Annual CFF
-$2.79 M
-$3.90 M-349.60%
31 December 2021
Summary:
As of January 25, 2025, LJPC annual cash flow from financing activities is -$2.79 million, with the most recent change of -$3.90 million (-349.60%) on December 31, 2021. During the last 3 years, it has fallen by -$239.19 million (-101.18%).LJPC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LJPC Quarterly CFF
-$2.78 M
+$2.24 M+44.54%
30 June 2022
Summary:
As of January 25, 2025, LJPC quarterly cash flow from financing activities is -$2.78 million, with the most recent change of +$2.24 million (+44.54%) on June 30, 2022. Over the past year, it has dropped by -$2.90 million (-2459.32%).LJPC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LJPC TTM CFF
-$10.95 M
-$2.90 M-36.08%
30 June 2022
Summary:
As of January 25, 2025, LJPC TTM cash flow from financing activities is -$10.95 million, with the most recent change of -$2.90 million (-36.08%) on June 30, 2022. Over the past year, it has dropped by -$11.45 million (-2263.04%).LJPC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LJPC Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -349.6% | -2459.3% | -2263.0% |
| 3 y3 years | -101.2% | -1485.1% | -1366.8% |
| 5 y5 years | -102.3% | -100.0% | -1366.8% |
LJPC Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -101.2% | -102.2% | -104.6% |
La Jolla Pharmaceutical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$2.78 M(-44.5%) | -$10.95 M(+36.1%) |
| Mar 2022 | - | -$5.02 M(+53.9%) | -$8.04 M(+188.5%) |
| Dec 2021 | -$2.79 M(-349.6%) | -$3.26 M(-2817.5%) | -$2.79 M(-600.5%) |
| Sept 2021 | - | $120.00 K(+1.7%) | $557.00 K(+10.1%) |
| June 2021 | - | $118.00 K(-49.8%) | $506.00 K(-40.3%) |
| Mar 2021 | - | $235.00 K(+179.8%) | $847.00 K(-24.2%) |
| Dec 2020 | $1.12 M(+29.3%) | $84.00 K(+21.7%) | $1.12 M(-9.6%) |
| Sept 2020 | - | $69.00 K(-85.0%) | $1.24 M(-8.0%) |
| June 2020 | - | $459.00 K(-9.1%) | $1.34 M(+23.8%) |
| Mar 2020 | - | $505.00 K(+148.8%) | $1.09 M(+25.7%) |
| Dec 2019 | $864.00 K(-99.6%) | $203.00 K(+14.7%) | $864.00 K(-17.9%) |
| Sept 2019 | - | $177.00 K(-11.9%) | $1.05 M(-1.4%) |
| June 2019 | - | $201.00 K(-29.0%) | $1.07 M(-99.2%) |
| Mar 2019 | - | $283.00 K(-27.6%) | $126.34 M(-46.6%) |
| Dec 2018 | $236.40 M(+96.7%) | $391.00 K(+103.6%) | $236.40 M(+0.0%) |
| Sept 2018 | - | $192.00 K(-99.8%) | $236.34 M(-0.0%) |
| June 2018 | - | $125.48 M(+13.7%) | $236.43 M(+113.1%) |
| Mar 2018 | - | $110.34 M(>+9900.0%) | $110.96 M(-7.7%) |
| Dec 2017 | $120.17 M(>+9900.0%) | $334.00 K(+17.2%) | $120.17 M(+0.2%) |
| Sept 2017 | - | $285.00 K(>+9900.0%) | $119.90 M(+0.2%) |
| June 2017 | - | $0.00(-100.0%) | $119.62 M(0.0%) |
| Mar 2017 | - | $119.55 M(>+9900.0%) | $119.62 M(>+9900.0%) |
| Dec 2016 | $149.00 K(-99.9%) | $64.00 K(>+9900.0%) | $149.00 K(+31.9%) |
| Sept 2016 | - | $0.00(0.0%) | $113.00 K(-99.9%) |
| June 2016 | - | $0.00(-100.0%) | $104.94 M(0.0%) |
| Mar 2016 | - | $85.00 K(+203.6%) | $104.94 M(+0.0%) |
| Dec 2015 | $104.91 M(+97.7%) | $28.00 K(-100.0%) | $104.91 M(+0.0%) |
| Sept 2015 | - | $104.83 M(>+9900.0%) | $104.88 M(+97.4%) |
| June 2015 | - | $0.00(-100.0%) | $53.12 M(0.0%) |
| Mar 2015 | - | $57.00 K(>+9900.0%) | $53.12 M(+0.1%) |
| Dec 2014 | $53.06 M(+430.6%) | $0.00(-100.0%) | $53.06 M(-0.0%) |
| Sept 2014 | - | $53.06 M(>+9900.0%) | $53.06 M(+430.6%) |
| June 2014 | - | $0.00(0.0%) | $10.00 M(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) | $10.00 M(0.0%) |
| Dec 2013 | $10.00 M(+1900.2%) | $1000.00(-100.0%) | $10.00 M(-4.8%) |
| Sept 2013 | - | $10.00 M(+1900.0%) | $10.50 M(+2000.0%) |
| Dec 2012 | $500.00 K(>+9900.0%) | $500.00 K(>+9900.0%) | $500.00 K(>+9900.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2011 | - | $0.00(0.0%) | $6.00 M(0.0%) |
| Dec 2010 | $6.00 M(+1098.2%) | $0.00(0.0%) | $6.00 M(0.0%) |
| Sept 2010 | - | $0.00(-100.0%) | $6.00 M(+0.7%) |
| June 2010 | - | $6.00 M(>+9900.0%) | $5.96 M(+1089.8%) |
| Dec 2009 | $501.00 K(-98.5%) | $0.00(-100.0%) | $501.00 K(-92.3%) |
| Sept 2009 | - | -$42.00 K(-86.2%) | $6.52 M(-0.3%) |
| June 2009 | - | -$305.00 K(-136.0%) | $6.54 M(-81.3%) |
| Mar 2009 | - | $848.00 K(-85.9%) | $34.99 M(+2.4%) |
| Dec 2008 | $34.17 M(-11.9%) | $6.02 M(<-9900.0%) | $34.17 M(+20.3%) |
| Sept 2008 | - | -$21.00 K(-100.1%) | $28.41 M(-0.2%) |
| June 2008 | - | $28.14 M(>+9900.0%) | $28.47 M(-26.3%) |
| Mar 2008 | - | $26.00 K(-90.1%) | $38.63 M(-0.4%) |
| Dec 2007 | $38.77 M | $263.00 K(+610.8%) | $38.77 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2007 | - | $37.00 K(-99.9%) | $38.86 M(+0.2%) |
| June 2007 | - | $38.30 M(>+9900.0%) | $38.78 M(+9668.5%) |
| Mar 2007 | - | $172.00 K(-50.6%) | $397.00 K(+346.1%) |
| Dec 2006 | $89.00 K(-99.9%) | $348.00 K(-928.6%) | $89.00 K(-99.9%) |
| Sept 2006 | - | -$42.00 K(-48.1%) | $62.17 M(+0.7%) |
| June 2006 | - | -$81.00 K(-40.4%) | $61.76 M(+0.1%) |
| Mar 2006 | - | -$136.00 K(-100.2%) | $61.67 M(-20.4%) |
| Dec 2005 | $77.44 M(+163.0%) | $62.43 M(<-9900.0%) | $77.44 M(+419.5%) |
| Sept 2005 | - | -$456.00 K(+173.1%) | $14.91 M(-3.4%) |
| June 2005 | - | -$167.00 K(-101.1%) | $15.43 M(-1.2%) |
| Mar 2005 | - | $15.63 M(<-9900.0%) | $15.62 M(-47.0%) |
| Dec 2004 | $29.44 M(+34.1%) | -$105.00 K(-264.1%) | $29.44 M(-0.9%) |
| Sept 2004 | - | $64.00 K(+166.7%) | $29.71 M(-41.3%) |
| June 2004 | - | $24.00 K(-99.9%) | $50.63 M(-1.6%) |
| Mar 2004 | - | $29.46 M(>+9900.0%) | $51.46 M(+134.4%) |
| Dec 2003 | $21.96 M(-56.1%) | $159.00 K(-99.2%) | $21.96 M(-2.3%) |
| Sept 2003 | - | $20.98 M(+2343.0%) | $22.46 M(+820.3%) |
| June 2003 | - | $859.00 K(-2008.9%) | $2.44 M(+48.9%) |
| Mar 2003 | - | -$45.00 K(-106.8%) | $1.64 M(-96.7%) |
| Dec 2002 | $50.03 M(+51.7%) | $665.00 K(-30.9%) | $50.03 M(+1.6%) |
| Sept 2002 | - | $962.00 K(+1587.7%) | $49.26 M(+2.1%) |
| June 2002 | - | $57.00 K(-99.9%) | $48.26 M(+0.3%) |
| Mar 2002 | - | $48.35 M(<-9900.0%) | $48.13 M(+45.9%) |
| Dec 2001 | $32.98 M(-18.5%) | -$108.00 K(+200.0%) | $32.98 M(-0.5%) |
| Sept 2001 | - | -$36.00 K(-50.0%) | $33.16 M(-45.4%) |
| June 2001 | - | -$72.00 K(-100.2%) | $60.68 M(-0.2%) |
| Mar 2001 | - | $33.20 M(>+9900.0%) | $60.80 M(+50.3%) |
| Dec 2000 | $40.44 M(<-9900.0%) | $73.00 K(-99.7%) | $40.44 M(+0.1%) |
| Sept 2000 | - | $27.49 M(>+9900.0%) | $40.39 M(+215.5%) |
| June 2000 | - | $41.00 K(-99.7%) | $12.80 M(+0.3%) |
| Mar 2000 | - | $12.84 M(>+9900.0%) | $12.76 M(<-9900.0%) |
| Dec 1999 | -$82.00 K(-102.1%) | $18.00 K(-118.0%) | -$82.00 K(-102.2%) |
| Sept 1999 | - | -$100.00 K(<-9900.0%) | $3.80 M(-2.6%) |
| June 1999 | - | $0.00(0.0%) | $3.90 M(-2.5%) |
| Mar 1999 | - | $0.00(-100.0%) | $4.00 M(+2.6%) |
| Dec 1998 | $3.90 M(+14.7%) | $3.90 M(>+9900.0%) | $3.90 M(>+9900.0%) |
| Sept 1998 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| June 1998 | - | $100.00 K(-200.0%) | $3.80 M(+5.6%) |
| Mar 1998 | - | -$100.00 K(<-9900.0%) | $3.60 M(+5.9%) |
| Dec 1997 | $3.40 M(-73.6%) | $0.00(-100.0%) | $3.40 M(-52.1%) |
| Sept 1997 | - | $3.80 M(-3900.0%) | $7.10 M(-45.0%) |
| June 1997 | - | -$100.00 K(-66.7%) | $12.90 M(+0.8%) |
| Mar 1997 | - | -$300.00 K(-108.1%) | $12.80 M(-0.8%) |
| Dec 1996 | $12.90 M(-25.4%) | $3.70 M(-61.5%) | $12.90 M(-25.0%) |
| Sept 1996 | - | $9.60 M(-4900.0%) | $17.20 M(+135.6%) |
| June 1996 | - | -$200.00 K(0.0%) | $7.30 M(-57.8%) |
| Mar 1996 | - | -$200.00 K(-102.5%) | $17.30 M(0.0%) |
| Dec 1995 | $17.30 M(+6.1%) | $8.00 M(-2766.7%) | $17.30 M(+90.1%) |
| Sept 1995 | - | -$300.00 K(-103.1%) | $9.10 M(+1.1%) |
| June 1995 | - | $9.80 M(-5000.0%) | $9.00 M(-44.4%) |
| Mar 1995 | - | -$200.00 K(0.0%) | $16.20 M(-0.6%) |
| Dec 1994 | $16.30 M | -$200.00 K(-50.0%) | $16.30 M(-1.2%) |
| Sept 1994 | - | -$400.00 K(-102.4%) | $16.50 M(-2.4%) |
| June 1994 | - | $17.00 M(<-9900.0%) | $16.90 M(<-9900.0%) |
| Mar 1994 | - | -$100.00 K | -$100.00 K |
FAQ
- What is La Jolla Pharmaceutical annual cash flow from financing activities?
- What is the all time high annual CFF for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical annual CFF year-on-year change?
- What is La Jolla Pharmaceutical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical quarterly CFF year-on-year change?
- What is La Jolla Pharmaceutical TTM cash flow from financing activities?
- What is the all time high TTM CFF for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical TTM CFF year-on-year change?
What is La Jolla Pharmaceutical annual cash flow from financing activities?
The current annual CFF of LJPC is -$2.79 M
What is the all time high annual CFF for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high annual cash flow from financing activities is $236.40 M
What is La Jolla Pharmaceutical annual CFF year-on-year change?
Over the past year, LJPC annual cash flow from financing activities has changed by -$3.90 M (-349.60%)
What is La Jolla Pharmaceutical quarterly cash flow from financing activities?
The current quarterly CFF of LJPC is -$2.78 M
What is the all time high quarterly CFF for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high quarterly cash flow from financing activities is $125.48 M
What is La Jolla Pharmaceutical quarterly CFF year-on-year change?
Over the past year, LJPC quarterly cash flow from financing activities has changed by -$2.90 M (-2459.32%)
What is La Jolla Pharmaceutical TTM cash flow from financing activities?
The current TTM CFF of LJPC is -$10.95 M
What is the all time high TTM CFF for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high TTM cash flow from financing activities is $236.43 M
What is La Jolla Pharmaceutical TTM CFF year-on-year change?
Over the past year, LJPC TTM cash flow from financing activities has changed by -$11.45 M (-2263.04%)